These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11784119)

  • 1. The Mallory body as an aggresome: in vitro studies.
    Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW
    Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p62 is involved in the mechanism of Mallory body formation.
    Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Fu AN; Francis T; Vu J; French SW
    Exp Mol Pathol; 2004 Dec; 77(3):168-75. PubMed ID: 15507232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.
    Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW
    Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).
    Bardag-Gorce F; Riley N; Nguyen V; Montgomery RO; French BA; Li J; van Leeuwen FW; Lungo W; McPhaul LW; French SW
    Exp Mol Pathol; 2003 Apr; 74(2):160-7. PubMed ID: 12710947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies.
    Bardag-Gorce F; van Leeuwen FW; Nguyen V; French BA; Li J; Riley N; McPhaul LW; Lue YH; French SW
    Exp Mol Pathol; 2002 Oct; 73(2):75-83. PubMed ID: 12231209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin.
    French BA; van Leeuwen F; Riley NE; Yuan QX; Bardag-Gorce F; Gaal K; Lue YH; Marceau N; French SW
    Exp Mol Pathol; 2001 Dec; 71(3):241-6. PubMed ID: 11733949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation.
    Bardag-Gorce F; Riley NE; Nan L; Montgomery RO; Li J; French BA; Lue YH; French SW
    Exp Mol Pathol; 2004 Feb; 76(1):9-16. PubMed ID: 14738863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens.
    Riley NE; Li J; McPhaul LW; Bardag-Gorce F; Lue YH; French SW
    Exp Mol Pathol; 2003 Apr; 74(2):168-72. PubMed ID: 12710948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mallory body forming cells express the preneoplastic hepatocyte phenotype.
    Nan L; Bardag-Gorce F; Wu Y; Li J; French BA; French SW
    Exp Mol Pathol; 2006 Apr; 80(2):109-18. PubMed ID: 16413534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.
    Yuan QX; Nagao Y; Gaal K; Hu B; French SW
    Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin-containing inclusions affect cell morphology and distribution of cytosolic cellular components.
    Hanada S; Harada M; Kumemura H; Omary MB; Kawaguchi T; Taniguchi E; Koga H; Yoshida T; Maeyama M; Baba S; Ueno T; Sata M
    Exp Cell Res; 2005 Apr; 304(2):471-82. PubMed ID: 15748892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.
    Riley NE; Bardag-Gorce F; Montgomery RO; Li J; Lungo W; Lue YH; French SW
    Exp Mol Pathol; 2003 Apr; 74(2):173-9. PubMed ID: 12710949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay.
    Kachi K; Cadrin M; French SW
    Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mallory body induction in drug-primed mouse liver.
    Yuan QX; Marceau N; French BA; Fu P; French SW
    Hepatology; 1996 Sep; 24(3):603-12. PubMed ID: 8781332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study.
    Bardag-Gorce F; French BA; Lue YH; Nguyen V; Wan YJ; French SW
    Exp Mol Pathol; 2001 Feb; 70(1):7-18. PubMed ID: 11170786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H; Marceau N; French SW
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation.
    Hirano K; Roth J; Zuber C; Ziak M
    Histochem Cell Biol; 2002 Jan; 117(1):41-53. PubMed ID: 11819096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference of VCP/p97 increases Mallory body formation.
    Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; Khanh Nguyen S; French SW
    Exp Mol Pathol; 2005 Feb; 78(1):1-9. PubMed ID: 15596054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.